Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02459106 · ClinicalTrials.gov registry record
Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans
A clinical trial, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- 46
- Enrollment target
NCT02459106: Completed study, sponsored by AdventHealth Translational Research Institute.
NCT02459106 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02459106 has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is examine the effect of fat tissue-released miRNA on skeletal muscle and if abnormal fat tissue-released miRNA contributes to insulin resistance in obese individuals. This information will be important for our understanding of how the body's sugar metabolism is regulated and why people who are obese become insulin resistant and are more likely to develop type 2 diabetes.
Primary Outcome
The effect of miRNA released by adipose tissue from lean insulin-sensitive and from obese insulin-resistant individuals on skeletal muscle biology and insulin signaling.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2015-05-27 |
| Est. Completion | 2024-12-19 |
What the finished NCT02459106 record still lists
NCT02459106 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02459106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02459106 about?
NCT02459106 is a clinical study titled "Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans". The purpose of this study is examine the effect of fat tissue-released miRNA on skeletal muscle and if abnormal fat tissue-released miRNA contributes to insulin resistance in obese individuals. This information will be important for our understanding of how the body's sugar metabolism is regulated a...
What is the current status of trial NCT02459106?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2015-05-27. Estimated completion is 2024-12-19.
Who is sponsoring clinical trial NCT02459106?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI